San Francisco, California
London, United Kingdom
CEPAC’s public deliberation of the evidence will provide clarity and guidance to clinicians, insurers, and policymakers confronted with decisions on how best to manage type 2 diabetes. Registration is free and open to the public, though a limited number of spaces are available.
For more information about CEPAC and further detail about the meeting, including voting questions and a meeting agenda, visit the CEPAC website.
Public Comment Process:
Written public comments on the draft assessment will be accepted by email via email@example.com until 5:00 PM ET on October 22, 2014.
Members of public wishing to deliver a public comment at the October 29, 2014 CEPAC meeting must email firstname.lastname@example.org by 5:00 PM ET October 24, 2014. Please note that slots for making a public comment are limited and will be assigned in the order that requests are received.
When & Where
Institute for Clinical and Economic Review
CEPAC, an independent, regional body of practicing physicians, methodological experts, as well as patient/public members, provides objective, independent guidance on the application of medical evidence to clinical practice and payer policy decisions across New England. Led by the Institute for Clinical and Economic Review, CEPAC was originally funded by a federal grant from the Agency for Healthcare Research and Quality (AHRQ), but is now supported by a broad coalition of state Medicaid leaders, integrated provider groups, public and private payers and patient representatives. For more information on CEPAC, please visit cepac.icer-review.org.
The Institute for Clinical and Economic Review (ICER) is an independent non-profit health care research organization dedicated to improving the interpretation and application of evidence in the health care system. For more information about ICER, please visit ICER's newly redesigned website: www.icer-review.org.